Global Opioid Induced Constipation Drugs Market Growth 2025-2031
The global Opioid Induced Constipation Drugs market size is predicted to grow from US$ 2827 million in 2025 to US$ 3740 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
LP Information, Inc. (LPI) ' newest research report, the “Opioid Induced Constipation Drugs Industry Forecast” looks at past sales and reviews total world Opioid Induced Constipation Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioid Induced Constipation Drugs sales for 2025 through 2031. With Opioid Induced Constipation Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Induced Constipation Drugs industry.
This Insight Report provides a comprehensive analysis of the global Opioid Induced Constipation Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Induced Constipation Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid Induced Constipation Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Induced Constipation Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Induced Constipation Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Induced Constipation Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Opioid Induced Constipation Drugs market?
What factors are driving Opioid Induced Constipation Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Induced Constipation Drugs market opportunities vary by end market size?
How does Opioid Induced Constipation Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
LP Information, Inc. (LPI) ' newest research report, the “Opioid Induced Constipation Drugs Industry Forecast” looks at past sales and reviews total world Opioid Induced Constipation Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioid Induced Constipation Drugs sales for 2025 through 2031. With Opioid Induced Constipation Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Induced Constipation Drugs industry.
This Insight Report provides a comprehensive analysis of the global Opioid Induced Constipation Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Induced Constipation Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid Induced Constipation Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Induced Constipation Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Induced Constipation Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Induced Constipation Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ironwood Pharmaceuticals Inc
- Daiichi Sankyo Co Ltd
- Pfizer
- Progenics Pharmaceuticals Inc
- Shionogi & Co., Ltd
- Allergan Plc
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma AG
- Mundipharma International Limited
- Ono Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma Inc
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
What is the 10-year outlook for the global Opioid Induced Constipation Drugs market?
What factors are driving Opioid Induced Constipation Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Induced Constipation Drugs market opportunities vary by end market size?
How does Opioid Induced Constipation Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bone and Joint Ingredients Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bone and Joint Ingredients by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bone and Joint Ingredients by Country/Region, 2020, 2024 & 2031
2.2 Bone and Joint Ingredients Segment by Type
2.2.1 Glucosamine and Chondroitin
2.2.2 Calcium
2.2.3 Others
2.3 Bone and Joint Ingredients Sales by Type
2.3.1 Global Bone and Joint Ingredients Sales Market Share by Type (2020-2025)
2.3.2 Global Bone and Joint Ingredients Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bone and Joint Ingredients Sale Price by Type (2020-2025)
2.4 Bone and Joint Ingredients Segment by Application
2.4.1 Dietary Supplements
2.4.2 Functional Food and Beverages
2.5 Bone and Joint Ingredients Sales by Application
2.5.1 Global Bone and Joint Ingredients Sale Market Share by Application (2020-2025)
2.5.2 Global Bone and Joint Ingredients Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bone and Joint Ingredients Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Bone and Joint Ingredients Breakdown Data by Company
3.1.1 Global Bone and Joint Ingredients Annual Sales by Company (2020-2025)
3.1.2 Global Bone and Joint Ingredients Sales Market Share by Company (2020-2025)
3.2 Global Bone and Joint Ingredients Annual Revenue by Company (2020-2025)
3.2.1 Global Bone and Joint Ingredients Revenue by Company (2020-2025)
3.2.2 Global Bone and Joint Ingredients Revenue Market Share by Company (2020-2025)
3.3 Global Bone and Joint Ingredients Sale Price by Company
3.4 Key Manufacturers Bone and Joint Ingredients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bone and Joint Ingredients Product Location Distribution
3.4.2 Players Bone and Joint Ingredients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BONE AND JOINT INGREDIENTS BY GEOGRAPHIC REGION
4.1 World Historic Bone and Joint Ingredients Market Size by Geographic Region (2020-2025)
4.1.1 Global Bone and Joint Ingredients Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bone and Joint Ingredients Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bone and Joint Ingredients Market Size by Country/Region (2020-2025)
4.2.1 Global Bone and Joint Ingredients Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bone and Joint Ingredients Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone and Joint Ingredients Sales Growth
4.4 APAC Bone and Joint Ingredients Sales Growth
4.5 Europe Bone and Joint Ingredients Sales Growth
4.6 Middle East & Africa Bone and Joint Ingredients Sales Growth
5 AMERICAS
5.1 Americas Bone and Joint Ingredients Sales by Country
5.1.1 Americas Bone and Joint Ingredients Sales by Country (2020-2025)
5.1.2 Americas Bone and Joint Ingredients Revenue by Country (2020-2025)
5.2 Americas Bone and Joint Ingredients Sales by Type (2020-2025)
5.3 Americas Bone and Joint Ingredients Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone and Joint Ingredients Sales by Region
6.1.1 APAC Bone and Joint Ingredients Sales by Region (2020-2025)
6.1.2 APAC Bone and Joint Ingredients Revenue by Region (2020-2025)
6.2 APAC Bone and Joint Ingredients Sales by Type (2020-2025)
6.3 APAC Bone and Joint Ingredients Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bone and Joint Ingredients by Country
7.1.1 Europe Bone and Joint Ingredients Sales by Country (2020-2025)
7.1.2 Europe Bone and Joint Ingredients Revenue by Country (2020-2025)
7.2 Europe Bone and Joint Ingredients Sales by Type (2020-2025)
7.3 Europe Bone and Joint Ingredients Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bone and Joint Ingredients by Country
8.1.1 Middle East & Africa Bone and Joint Ingredients Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bone and Joint Ingredients Revenue by Country (2020-2025)
8.2 Middle East & Africa Bone and Joint Ingredients Sales by Type (2020-2025)
8.3 Middle East & Africa Bone and Joint Ingredients Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone and Joint Ingredients
10.3 Manufacturing Process Analysis of Bone and Joint Ingredients
10.4 Industry Chain Structure of Bone and Joint Ingredients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bone and Joint Ingredients Distributors
11.3 Bone and Joint Ingredients Customer
12 WORLD FORECAST REVIEW FOR BONE AND JOINT INGREDIENTS BY GEOGRAPHIC REGION
12.1 Global Bone and Joint Ingredients Market Size Forecast by Region
12.1.1 Global Bone and Joint Ingredients Forecast by Region (2026-2031)
12.1.2 Global Bone and Joint Ingredients Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bone and Joint Ingredients Forecast by Type (2026-2031)
12.7 Global Bone and Joint Ingredients Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Synutra
13.1.1 Synutra Company Information
13.1.2 Synutra Bone and Joint Ingredients Product Portfolios and Specifications
13.1.3 Synutra Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Synutra Main Business Overview
13.1.5 Synutra Latest Developments
13.2 Rousselot
13.2.1 Rousselot Company Information
13.2.2 Rousselot Bone and Joint Ingredients Product Portfolios and Specifications
13.2.3 Rousselot Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rousselot Main Business Overview
13.2.5 Rousselot Latest Developments
13.3 Waitaki Bio
13.3.1 Waitaki Bio Company Information
13.3.2 Waitaki Bio Bone and Joint Ingredients Product Portfolios and Specifications
13.3.3 Waitaki Bio Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Waitaki Bio Main Business Overview
13.3.5 Waitaki Bio Latest Developments
13.4 Royal DSM
13.4.1 Royal DSM Company Information
13.4.2 Royal DSM Bone and Joint Ingredients Product Portfolios and Specifications
13.4.3 Royal DSM Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Royal DSM Main Business Overview
13.4.5 Royal DSM Latest Developments
13.5 DuPont
13.5.1 DuPont Company Information
13.5.2 DuPont Bone and Joint Ingredients Product Portfolios and Specifications
13.5.3 DuPont Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DuPont Main Business Overview
13.5.5 DuPont Latest Developments
13.6 Archer Daniels Midland
13.6.1 Archer Daniels Midland Company Information
13.6.2 Archer Daniels Midland Bone and Joint Ingredients Product Portfolios and Specifications
13.6.3 Archer Daniels Midland Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Archer Daniels Midland Main Business Overview
13.6.5 Archer Daniels Midland Latest Developments
13.7 BASF
13.7.1 BASF Company Information
13.7.2 BASF Bone and Joint Ingredients Product Portfolios and Specifications
13.7.3 BASF Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BASF Main Business Overview
13.7.5 BASF Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bone and Joint Ingredients Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bone and Joint Ingredients by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bone and Joint Ingredients by Country/Region, 2020, 2024 & 2031
2.2 Bone and Joint Ingredients Segment by Type
2.2.1 Glucosamine and Chondroitin
2.2.2 Calcium
2.2.3 Others
2.3 Bone and Joint Ingredients Sales by Type
2.3.1 Global Bone and Joint Ingredients Sales Market Share by Type (2020-2025)
2.3.2 Global Bone and Joint Ingredients Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bone and Joint Ingredients Sale Price by Type (2020-2025)
2.4 Bone and Joint Ingredients Segment by Application
2.4.1 Dietary Supplements
2.4.2 Functional Food and Beverages
2.5 Bone and Joint Ingredients Sales by Application
2.5.1 Global Bone and Joint Ingredients Sale Market Share by Application (2020-2025)
2.5.2 Global Bone and Joint Ingredients Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bone and Joint Ingredients Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Bone and Joint Ingredients Breakdown Data by Company
3.1.1 Global Bone and Joint Ingredients Annual Sales by Company (2020-2025)
3.1.2 Global Bone and Joint Ingredients Sales Market Share by Company (2020-2025)
3.2 Global Bone and Joint Ingredients Annual Revenue by Company (2020-2025)
3.2.1 Global Bone and Joint Ingredients Revenue by Company (2020-2025)
3.2.2 Global Bone and Joint Ingredients Revenue Market Share by Company (2020-2025)
3.3 Global Bone and Joint Ingredients Sale Price by Company
3.4 Key Manufacturers Bone and Joint Ingredients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bone and Joint Ingredients Product Location Distribution
3.4.2 Players Bone and Joint Ingredients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BONE AND JOINT INGREDIENTS BY GEOGRAPHIC REGION
4.1 World Historic Bone and Joint Ingredients Market Size by Geographic Region (2020-2025)
4.1.1 Global Bone and Joint Ingredients Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bone and Joint Ingredients Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bone and Joint Ingredients Market Size by Country/Region (2020-2025)
4.2.1 Global Bone and Joint Ingredients Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bone and Joint Ingredients Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone and Joint Ingredients Sales Growth
4.4 APAC Bone and Joint Ingredients Sales Growth
4.5 Europe Bone and Joint Ingredients Sales Growth
4.6 Middle East & Africa Bone and Joint Ingredients Sales Growth
5 AMERICAS
5.1 Americas Bone and Joint Ingredients Sales by Country
5.1.1 Americas Bone and Joint Ingredients Sales by Country (2020-2025)
5.1.2 Americas Bone and Joint Ingredients Revenue by Country (2020-2025)
5.2 Americas Bone and Joint Ingredients Sales by Type (2020-2025)
5.3 Americas Bone and Joint Ingredients Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone and Joint Ingredients Sales by Region
6.1.1 APAC Bone and Joint Ingredients Sales by Region (2020-2025)
6.1.2 APAC Bone and Joint Ingredients Revenue by Region (2020-2025)
6.2 APAC Bone and Joint Ingredients Sales by Type (2020-2025)
6.3 APAC Bone and Joint Ingredients Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bone and Joint Ingredients by Country
7.1.1 Europe Bone and Joint Ingredients Sales by Country (2020-2025)
7.1.2 Europe Bone and Joint Ingredients Revenue by Country (2020-2025)
7.2 Europe Bone and Joint Ingredients Sales by Type (2020-2025)
7.3 Europe Bone and Joint Ingredients Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bone and Joint Ingredients by Country
8.1.1 Middle East & Africa Bone and Joint Ingredients Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bone and Joint Ingredients Revenue by Country (2020-2025)
8.2 Middle East & Africa Bone and Joint Ingredients Sales by Type (2020-2025)
8.3 Middle East & Africa Bone and Joint Ingredients Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bone and Joint Ingredients
10.3 Manufacturing Process Analysis of Bone and Joint Ingredients
10.4 Industry Chain Structure of Bone and Joint Ingredients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bone and Joint Ingredients Distributors
11.3 Bone and Joint Ingredients Customer
12 WORLD FORECAST REVIEW FOR BONE AND JOINT INGREDIENTS BY GEOGRAPHIC REGION
12.1 Global Bone and Joint Ingredients Market Size Forecast by Region
12.1.1 Global Bone and Joint Ingredients Forecast by Region (2026-2031)
12.1.2 Global Bone and Joint Ingredients Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bone and Joint Ingredients Forecast by Type (2026-2031)
12.7 Global Bone and Joint Ingredients Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Synutra
13.1.1 Synutra Company Information
13.1.2 Synutra Bone and Joint Ingredients Product Portfolios and Specifications
13.1.3 Synutra Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Synutra Main Business Overview
13.1.5 Synutra Latest Developments
13.2 Rousselot
13.2.1 Rousselot Company Information
13.2.2 Rousselot Bone and Joint Ingredients Product Portfolios and Specifications
13.2.3 Rousselot Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rousselot Main Business Overview
13.2.5 Rousselot Latest Developments
13.3 Waitaki Bio
13.3.1 Waitaki Bio Company Information
13.3.2 Waitaki Bio Bone and Joint Ingredients Product Portfolios and Specifications
13.3.3 Waitaki Bio Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Waitaki Bio Main Business Overview
13.3.5 Waitaki Bio Latest Developments
13.4 Royal DSM
13.4.1 Royal DSM Company Information
13.4.2 Royal DSM Bone and Joint Ingredients Product Portfolios and Specifications
13.4.3 Royal DSM Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Royal DSM Main Business Overview
13.4.5 Royal DSM Latest Developments
13.5 DuPont
13.5.1 DuPont Company Information
13.5.2 DuPont Bone and Joint Ingredients Product Portfolios and Specifications
13.5.3 DuPont Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DuPont Main Business Overview
13.5.5 DuPont Latest Developments
13.6 Archer Daniels Midland
13.6.1 Archer Daniels Midland Company Information
13.6.2 Archer Daniels Midland Bone and Joint Ingredients Product Portfolios and Specifications
13.6.3 Archer Daniels Midland Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Archer Daniels Midland Main Business Overview
13.6.5 Archer Daniels Midland Latest Developments
13.7 BASF
13.7.1 BASF Company Information
13.7.2 BASF Bone and Joint Ingredients Product Portfolios and Specifications
13.7.3 BASF Bone and Joint Ingredients Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BASF Main Business Overview
13.7.5 BASF Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Induced Constipation Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Opioid Induced Constipation Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Methyl Naltrexone Bromide
Table 5. Major Players of Naldemedine
Table 6. Major Players of Alvimopan
Table 7. Major Players of Others
Table 8. Global Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Table 10. Global Opioid Induced Constipation Drugs Revenue by Type (2020-2025) & ($ million)
Table 11. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2020-2025)
Table 12. Global Opioid Induced Constipation Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Opioid Induced Constipation Drugs Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Opioid Induced Constipation Drugs Sale Market Share by Application (2020-2025)
Table 15. Global Opioid Induced Constipation Drugs Revenue by Application (2020-2025) & ($ million)
Table 16. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2020-2025)
Table 17. Global Opioid Induced Constipation Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Opioid Induced Constipation Drugs Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Opioid Induced Constipation Drugs Sales Market Share by Company (2020-2025)
Table 20. Global Opioid Induced Constipation Drugs Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Opioid Induced Constipation Drugs Revenue Market Share by Company (2020-2025)
Table 22. Global Opioid Induced Constipation Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Opioid Induced Constipation Drugs Producing Area Distribution and Sales Area
Table 24. Players Opioid Induced Constipation Drugs Products Offered
Table 25. Opioid Induced Constipation Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Opioid Induced Constipation Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Opioid Induced Constipation Drugs Sales Market Share Geographic Region (2020-2025)
Table 30. Global Opioid Induced Constipation Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Opioid Induced Constipation Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Opioid Induced Constipation Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Opioid Induced Constipation Drugs Sales Market Share by Country/Region (2020-2025)
Table 34. Global Opioid Induced Constipation Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Opioid Induced Constipation Drugs Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2025)
Table 38. Americas Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Opioid Induced Constipation Drugs Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Opioid Induced Constipation Drugs Sales Market Share by Region (2020-2025)
Table 43. APAC Opioid Induced Constipation Drugs Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation Drugs
Table 55. Key Market Challenges & Risks of Opioid Induced Constipation Drugs
Table 56. Key Industry Trends of Opioid Induced Constipation Drugs
Table 57. Opioid Induced Constipation Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Opioid Induced Constipation Drugs Distributors List
Table 60. Opioid Induced Constipation Drugs Customer List
Table 61. Global Opioid Induced Constipation Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Opioid Induced Constipation Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Opioid Induced Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Opioid Induced Constipation Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Opioid Induced Constipation Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Opioid Induced Constipation Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Opioid Induced Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Opioid Induced Constipation Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Opioid Induced Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Opioid Induced Constipation Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Opioid Induced Constipation Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Opioid Induced Constipation Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Opioid Induced Constipation Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Opioid Induced Constipation Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Ironwood Pharmaceuticals Inc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 77. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Ironwood Pharmaceuticals Inc Main Business
Table 79. Ironwood Pharmaceuticals Inc Latest Developments
Table 80. Daiichi Sankyo Co Ltd Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 82. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Daiichi Sankyo Co Ltd Main Business
Table 84. Daiichi Sankyo Co Ltd Latest Developments
Table 85. Pfizer Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 87. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Progenics Pharmaceuticals Inc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 92. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Progenics Pharmaceuticals Inc Main Business
Table 94. Progenics Pharmaceuticals Inc Latest Developments
Table 95. Shionogi & Co., Ltd Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 97. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Shionogi & Co., Ltd Main Business
Table 99. Shionogi & Co., Ltd Latest Developments
Table 100. Allergan Plc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Allergan Plc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 102. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Allergan Plc Main Business
Table 104. Allergan Plc Latest Developments
Table 105. Nektar Therapeutics Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Nektar Therapeutics Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 107. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Nektar Therapeutics Main Business
Table 109. Nektar Therapeutics Latest Developments
Table 110. Purdue Pharma Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Purdue Pharma Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 112. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Purdue Pharma Main Business
Table 114. Purdue Pharma Latest Developments
Table 115. S.L.A. Pharma AG Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 117. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. S.L.A. Pharma AG Main Business
Table 119. S.L.A. Pharma AG Latest Developments
Table 120. Mundipharma International Limited Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Mundipharma International Limited Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 122. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Mundipharma International Limited Main Business
Table 124. Mundipharma International Limited Latest Developments
Table 125. Ono Pharmaceutical Co., Ltd Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 127. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Ono Pharmaceutical Co., Ltd Main Business
Table 129. Ono Pharmaceutical Co., Ltd Latest Developments
Table 130. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 132. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Company Limited Main Business
Table 134. Takeda Pharmaceutical Company Limited Latest Developments
Table 135. Theravance Biopharma Inc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 137. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Theravance Biopharma Inc Main Business
Table 139. Theravance Biopharma Inc Latest Developments
Table 140. Bausch Health Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Bausch Health Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 142. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Bausch Health Main Business
Table 144. Bausch Health Latest Developments
Table 145. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 147. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Cosmo Pharmaceuticals SA Main Business
Table 149. Cosmo Pharmaceuticals SA Latest Developments
Table 150. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 152. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Daewoong Pharmaceutical Main Business
Table 154. Daewoong Pharmaceutical Latest Developments
Table 155. C.B. Fleet Company Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. C.B. Fleet Company Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 157. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. C.B. Fleet Company Main Business
Table 159. C.B. Fleet Company Latest Developments
Table 160. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 162. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Sucampo Pharmaceuticals Main Business
Table 164. Sucampo Pharmaceuticals Latest Developments
Table 1. Opioid Induced Constipation Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Opioid Induced Constipation Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Methyl Naltrexone Bromide
Table 5. Major Players of Naldemedine
Table 6. Major Players of Alvimopan
Table 7. Major Players of Others
Table 8. Global Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Table 10. Global Opioid Induced Constipation Drugs Revenue by Type (2020-2025) & ($ million)
Table 11. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2020-2025)
Table 12. Global Opioid Induced Constipation Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Opioid Induced Constipation Drugs Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Opioid Induced Constipation Drugs Sale Market Share by Application (2020-2025)
Table 15. Global Opioid Induced Constipation Drugs Revenue by Application (2020-2025) & ($ million)
Table 16. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2020-2025)
Table 17. Global Opioid Induced Constipation Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Opioid Induced Constipation Drugs Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Opioid Induced Constipation Drugs Sales Market Share by Company (2020-2025)
Table 20. Global Opioid Induced Constipation Drugs Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Opioid Induced Constipation Drugs Revenue Market Share by Company (2020-2025)
Table 22. Global Opioid Induced Constipation Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Opioid Induced Constipation Drugs Producing Area Distribution and Sales Area
Table 24. Players Opioid Induced Constipation Drugs Products Offered
Table 25. Opioid Induced Constipation Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Opioid Induced Constipation Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Opioid Induced Constipation Drugs Sales Market Share Geographic Region (2020-2025)
Table 30. Global Opioid Induced Constipation Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Opioid Induced Constipation Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Opioid Induced Constipation Drugs Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Opioid Induced Constipation Drugs Sales Market Share by Country/Region (2020-2025)
Table 34. Global Opioid Induced Constipation Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Opioid Induced Constipation Drugs Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2025)
Table 38. Americas Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Opioid Induced Constipation Drugs Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Opioid Induced Constipation Drugs Sales Market Share by Region (2020-2025)
Table 43. APAC Opioid Induced Constipation Drugs Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Opioid Induced Constipation Drugs Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Opioid Induced Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Opioid Induced Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Opioid Induced Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation Drugs
Table 55. Key Market Challenges & Risks of Opioid Induced Constipation Drugs
Table 56. Key Industry Trends of Opioid Induced Constipation Drugs
Table 57. Opioid Induced Constipation Drugs Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Opioid Induced Constipation Drugs Distributors List
Table 60. Opioid Induced Constipation Drugs Customer List
Table 61. Global Opioid Induced Constipation Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Opioid Induced Constipation Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Opioid Induced Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Opioid Induced Constipation Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Opioid Induced Constipation Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Opioid Induced Constipation Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Opioid Induced Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Opioid Induced Constipation Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Opioid Induced Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Opioid Induced Constipation Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Opioid Induced Constipation Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Opioid Induced Constipation Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Opioid Induced Constipation Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Opioid Induced Constipation Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Ironwood Pharmaceuticals Inc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 77. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Ironwood Pharmaceuticals Inc Main Business
Table 79. Ironwood Pharmaceuticals Inc Latest Developments
Table 80. Daiichi Sankyo Co Ltd Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 82. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Daiichi Sankyo Co Ltd Main Business
Table 84. Daiichi Sankyo Co Ltd Latest Developments
Table 85. Pfizer Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 87. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Progenics Pharmaceuticals Inc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 92. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Progenics Pharmaceuticals Inc Main Business
Table 94. Progenics Pharmaceuticals Inc Latest Developments
Table 95. Shionogi & Co., Ltd Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 97. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Shionogi & Co., Ltd Main Business
Table 99. Shionogi & Co., Ltd Latest Developments
Table 100. Allergan Plc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Allergan Plc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 102. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Allergan Plc Main Business
Table 104. Allergan Plc Latest Developments
Table 105. Nektar Therapeutics Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Nektar Therapeutics Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 107. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Nektar Therapeutics Main Business
Table 109. Nektar Therapeutics Latest Developments
Table 110. Purdue Pharma Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Purdue Pharma Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 112. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Purdue Pharma Main Business
Table 114. Purdue Pharma Latest Developments
Table 115. S.L.A. Pharma AG Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 117. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. S.L.A. Pharma AG Main Business
Table 119. S.L.A. Pharma AG Latest Developments
Table 120. Mundipharma International Limited Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Mundipharma International Limited Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 122. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Mundipharma International Limited Main Business
Table 124. Mundipharma International Limited Latest Developments
Table 125. Ono Pharmaceutical Co., Ltd Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 127. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Ono Pharmaceutical Co., Ltd Main Business
Table 129. Ono Pharmaceutical Co., Ltd Latest Developments
Table 130. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 132. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Company Limited Main Business
Table 134. Takeda Pharmaceutical Company Limited Latest Developments
Table 135. Theravance Biopharma Inc Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 137. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Theravance Biopharma Inc Main Business
Table 139. Theravance Biopharma Inc Latest Developments
Table 140. Bausch Health Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Bausch Health Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 142. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Bausch Health Main Business
Table 144. Bausch Health Latest Developments
Table 145. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 147. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Cosmo Pharmaceuticals SA Main Business
Table 149. Cosmo Pharmaceuticals SA Latest Developments
Table 150. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 152. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Daewoong Pharmaceutical Main Business
Table 154. Daewoong Pharmaceutical Latest Developments
Table 155. C.B. Fleet Company Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. C.B. Fleet Company Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 157. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. C.B. Fleet Company Main Business
Table 159. C.B. Fleet Company Latest Developments
Table 160. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 161. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Portfolios and Specifications
Table 162. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Sucampo Pharmaceuticals Main Business
Table 164. Sucampo Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Induced Constipation Drugs
Figure 2. Opioid Induced Constipation Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Induced Constipation Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Opioid Induced Constipation Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Opioid Induced Constipation Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Opioid Induced Constipation Drugs Sales Market Share by Country/Region (2024)
Figure 10. Opioid Induced Constipation Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lubiprostone
Figure 12. Product Picture of Methyl Naltrexone Bromide
Figure 13. Product Picture of Naldemedine
Figure 14. Product Picture of Alvimopan
Figure 15. Product Picture of Others
Figure 16. Global Opioid Induced Constipation Drugs Sales Market Share by Type in 2025
Figure 17. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2020-2025)
Figure 18. Opioid Induced Constipation Drugs Consumed in Hospital Pharmacies
Figure 19. Global Opioid Induced Constipation Drugs Market: Hospital Pharmacies (2020-2025) & (K Pcs)
Figure 20. Opioid Induced Constipation Drugs Consumed in Retail Pharmacies
Figure 21. Global Opioid Induced Constipation Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
Figure 22. Opioid Induced Constipation Drugs Consumed in Online Pharmacies
Figure 23. Global Opioid Induced Constipation Drugs Market: Online Pharmacies (2020-2025) & (K Pcs)
Figure 24. Global Opioid Induced Constipation Drugs Sale Market Share by Application (2024)
Figure 25. Global Opioid Induced Constipation Drugs Revenue Market Share by Application in 2025
Figure 26. Opioid Induced Constipation Drugs Sales by Company in 2025 (K Pcs)
Figure 27. Global Opioid Induced Constipation Drugs Sales Market Share by Company in 2025
Figure 28. Opioid Induced Constipation Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Opioid Induced Constipation Drugs Revenue Market Share by Company in 2025
Figure 30. Global Opioid Induced Constipation Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Opioid Induced Constipation Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 33. Americas Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 35. APAC Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 37. Europe Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Opioid Induced Constipation Drugs Sales Market Share by Country in 2025
Figure 41. Americas Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Opioid Induced Constipation Drugs Sales Market Share by Region in 2025
Figure 49. APAC Opioid Induced Constipation Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Opioid Induced Constipation Drugs Sales Market Share by Country in 2025
Figure 60. Europe Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Opioid Induced Constipation Drugs in 2025
Figure 77. Manufacturing Process Analysis of Opioid Induced Constipation Drugs
Figure 78. Industry Chain Structure of Opioid Induced Constipation Drugs
Figure 79. Channels of Distribution
Figure 80. Global Opioid Induced Constipation Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global Opioid Induced Constipation Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Opioid Induced Constipation Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Opioid Induced Constipation Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Opioid Induced Constipation Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Opioid Induced Constipation Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Opioid Induced Constipation Drugs
Figure 2. Opioid Induced Constipation Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Induced Constipation Drugs Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Opioid Induced Constipation Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Opioid Induced Constipation Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Opioid Induced Constipation Drugs Sales Market Share by Country/Region (2024)
Figure 10. Opioid Induced Constipation Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lubiprostone
Figure 12. Product Picture of Methyl Naltrexone Bromide
Figure 13. Product Picture of Naldemedine
Figure 14. Product Picture of Alvimopan
Figure 15. Product Picture of Others
Figure 16. Global Opioid Induced Constipation Drugs Sales Market Share by Type in 2025
Figure 17. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2020-2025)
Figure 18. Opioid Induced Constipation Drugs Consumed in Hospital Pharmacies
Figure 19. Global Opioid Induced Constipation Drugs Market: Hospital Pharmacies (2020-2025) & (K Pcs)
Figure 20. Opioid Induced Constipation Drugs Consumed in Retail Pharmacies
Figure 21. Global Opioid Induced Constipation Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
Figure 22. Opioid Induced Constipation Drugs Consumed in Online Pharmacies
Figure 23. Global Opioid Induced Constipation Drugs Market: Online Pharmacies (2020-2025) & (K Pcs)
Figure 24. Global Opioid Induced Constipation Drugs Sale Market Share by Application (2024)
Figure 25. Global Opioid Induced Constipation Drugs Revenue Market Share by Application in 2025
Figure 26. Opioid Induced Constipation Drugs Sales by Company in 2025 (K Pcs)
Figure 27. Global Opioid Induced Constipation Drugs Sales Market Share by Company in 2025
Figure 28. Opioid Induced Constipation Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Opioid Induced Constipation Drugs Revenue Market Share by Company in 2025
Figure 30. Global Opioid Induced Constipation Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Opioid Induced Constipation Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 33. Americas Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 35. APAC Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 37. Europe Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Opioid Induced Constipation Drugs Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Opioid Induced Constipation Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Opioid Induced Constipation Drugs Sales Market Share by Country in 2025
Figure 41. Americas Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 43. Americas Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Opioid Induced Constipation Drugs Sales Market Share by Region in 2025
Figure 49. APAC Opioid Induced Constipation Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 51. APAC Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Opioid Induced Constipation Drugs Sales Market Share by Country in 2025
Figure 60. Europe Opioid Induced Constipation Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 62. Europe Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. France Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Opioid Induced Constipation Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Opioid Induced Constipation Drugs in 2025
Figure 77. Manufacturing Process Analysis of Opioid Induced Constipation Drugs
Figure 78. Industry Chain Structure of Opioid Induced Constipation Drugs
Figure 79. Channels of Distribution
Figure 80. Global Opioid Induced Constipation Drugs Sales Market Forecast by Region (2026-2031)
Figure 81. Global Opioid Induced Constipation Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Opioid Induced Constipation Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Opioid Induced Constipation Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Opioid Induced Constipation Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Opioid Induced Constipation Drugs Revenue Market Share Forecast by Application (2026-2031)
